Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Rolapitant Hydrochloride

Base Information
  • Chemical Name:Rolapitant Hydrochloride
  • CAS No.:914462-92-3
  • Molecular Formula:C25H29ClF6N2O3
  • Molecular Weight:554.96
  • Hs Code.:
  • European Community (EC) Number:682-730-5
  • UNII:57O5S1QSAQ
  • ChEMBL ID:CHEMBL3707330
  • DSSTox Substance ID:DTXSID70238570
  • NCI Thesaurus Code:C97955
  • RXCUI:1673367
  • Wikidata:Q27162902
  • Mol file:914462-92-3.mol
Rolapitant Hydrochloride

Synonyms:(5S,8S)-8-(((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4.5)decan-2-one;8-((1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4,5)decan-2-one;rolapitant;SCH 619734;Varubi

Suppliers and Price of Rolapitant Hydrochloride
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • RolapitantHydrochlorideHydrate
  • 5mg
  • $ 275.00
  • Matrix Scientific
  • Rolapitant 95+%
  • 1g
  • $ 11880.00
  • Biosynth Carbosynth
  • Rolapitant hydrochloride monohydrate
  • 50 mg
  • $ 350.00
  • Biosynth Carbosynth
  • Rolapitant hydrochloride monohydrate
  • 25 mg
  • $ 250.00
  • Biosynth Carbosynth
  • Rolapitant hydrochloride monohydrate
  • 10 mg
  • $ 170.00
  • Biosynth Carbosynth
  • Rolapitant hydrochloride monohydrate
  • 100 mg
  • $ 450.00
  • Biosynth Carbosynth
  • Rolapitant hydrochloride monohydrate
  • 250 mg
  • $ 600.00
  • American Custom Chemicals Corporation
  • ROLAPITANT 95.00%
  • 1G
  • $ 10905.30
  • American Custom Chemicals Corporation
  • ROLAPITANT 95.00%
  • 5MG
  • $ 498.99
  • AK Scientific
  • Rolapitanthydrochloride
  • 25mg
  • $ 387.00
Total 46 raw suppliers
Chemical Property of Rolapitant Hydrochloride
Chemical Property:
  • PSA:59.59000 
  • LogP:7.12480 
  • Storage Temp.:Hygroscopic, -20°C Freezer, Under inert atmosphere 
  • Solubility.:DMSO (Slightly), Methanol (Slightly) 
  • Hydrogen Bond Donor Count:4
  • Hydrogen Bond Acceptor Count:10
  • Rotatable Bond Count:5
  • Exact Mass:554.1770895
  • Heavy Atom Count:37
  • Complexity:731
Purity/Quality:

99%, *data from raw suppliers

RolapitantHydrochlorideHydrate *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4.O.Cl
  • Isomeric SMILES:C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4.O.Cl
  • Recent ClinicalTrials:Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy
  • Recent EU Clinical Trials:A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy (HEC)
  • Description Rolapitant hydrochloride hydrate, originally discovered by Schering-Plough and later developed by TESARO, Inc., was approved by the FDA in September 2015 for the prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in combination with other antiemetic agents. Rolapitant is a highly selective NK-1 receptor antagonist, exhibiting >1000- fold selectivity for NK-1 over human NK-2 and NK-3 receptors in vitro. In contrast to other NK-1 inhibitors that play an essential role in delayed CINV therapy, rolapitant shows no inhibition of CYP3A4, eliminating the need for concern when coadministering with CYP34A substrates. Additionally, rolapitant is an orally active agent with a relatively long half-life (180 h), providing potential opportunities for single- and prechemotherapy-based treatments. In three large clinical trials involving patients receiving moderately emetogenic chemotherapy (MEC) and highly emetogenic chemotherapy (HEC), subjects using rolapitant as a cotherapy with granisetron and dexamethasone showed a significant improvement in complete response compared to those receiving treatments of granisetron and dexamethasone.
  • Uses Rolapitant Hydrochloride Hydrate is a raw material for pharmaceutical formulations.
Technology Process of Rolapitant Hydrochloride

There total 1 articles about Rolapitant Hydrochloride which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With hydrogenchloride; water; In ethanol; isopropyl alcohol; at 0 - 25 ℃; for 1.41667h; Product distribution / selectivity;
upstream raw materials:

Rolapitant

Downstream raw materials:

Rolapitant hydrochloride

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 914462-92-3